CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Formato: Artigo
Idioma:Russo
Publicado: IRBIS LLC 2016-02-01
Series:Фармакоэкономика
Assuntos:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Acceso en liña:https://www.pharmacoeconomics.ru/jour/article/view/130
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares